Sometimes, the diarrhea associated with C
Pharmacokinetics, safety and tolerability of once-weekly subcutaneous semaglutide in healthy Chinese subjects: a double-blind, phase 1, randomized controlled trial
The higher rate in the GLP-1 group suggests something specific about the medication class rather than the underlying condition being treated
5-12 However, in clinical trials, including SURMOUNT-1 for tirzepatide and STEP 1 for semaglutide, participants were permitted to remain on a given dose for up to 4 additional weeks, as needed, to allow for the dissipation of any GI AEs
It's all encompassing of genetic, occupational, hormonal, physical, mental, and social factors," said Dr